HCM
HUTCHMED DRC
NASDAQ: HCM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.36
-1.69% today
Updated 2026-04-29
Market cap
$2.30B
P/E ratio
5.04
P/S ratio
4.19x
EPS (TTM)
$2.65
Dividend yield
—
52W range
$13 – $20
Volume
0.0M
HUTCHMED DRC (HCM) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.36
12-Month target
$13.80
2030 Target
—
Intrinsic (DCF)
$31.70
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.8B | $0.6B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 5.04x (capped 25x) · Margin: 83.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.